House Democrats Raise Drug Access Concerns With HHS Standards For Essential Health Benefits
Executive Summary
Authors of the Affordable Care Act are concerned that HHS’ approach to implementing the “essential health benefits” requirement for insurance plans available through state-based exchanges may lead to drug coverage that is more restrictive than the law intended.
You may also be interested in...
HHS Essential Health Benefits Standard Would Allow Plans To Cover One Drug Per Category
Released Dec. 16, the HHS bulletin previews the regulatory approach the department plans to propose to define covered services under the EHB standard, which must be followed by plans participating in state-based insurance exchanges that will start operating in 2014 under the Affordable Care Act.
Xtandi Pricing and Patents: Alternatives To March-In Urged To Lower Medicare, Medicaid Costs
The timing of the request, with Xtandi’s loss of exclusivity on the horizon, could be explained by the concern that a change in the US presidential administration in 2025 may limit the prospects for near-term relief.
Medicare-Negotiated Drugs May Not Get Favorable Coverage In Part D: Will CMS Intervene?
Insurance plans put on notice that CMS is concerned about restrictions on drugs with negotiated prices, but it’s not clear what the agency can or will do about it.